Press release

MWI Animal Health Announces New Offerings to Alleviate Financial Burdens of Pet Care

Two flexible financing solutions make essential pet care more affordable in the wake of COVID-19

 

BOISE, Idaho – MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today announced two new offerings designed to increase access to affordable veterinary care as practices and their clients grapple with the financial impacts of the novel coronavirus (COVID-19). The offerings enable practices to provide flexible financing solutions for clients who may be struggling to afford quality care for their pets or who may just want more certainty in an uncertain economic landscape.

“As part of our commitment to creating healthier futures, we are always listening, adapting and responding to our customers’ evolving needs—particularly today as veterinary practices and their clients continue to navigate the long-term effects of this global health crisis,” said Brian Topper, Vice President of Product Strategy at MWI. “We know that COVID-19 has led to uncertainty and unemployment for millions of people who are now having to make difficult decisions. Whether or not to get necessary care for their pets should not be one of them. These new partnerships will ease the financial burden of both routine and emergency pet care, while also helping practices achieve more consistent revenue, long term client engagement, and, most importantly, better outcome for their patients.”

Through MWI, veterinary practices can now offer the following financial solutions to their clients:

  • Premier Pet Care Plan: The custom-built care plans provide gold standard medicine, such as vaccinations and preventative care, via monthly payments to help spread out the cost of routine products and services. By offering a simple, manageable way for clients to meet essential pet healthcare needs, and simultaneously removing much of the administrative burden from practices, the Premier Pet Care Plan enables veterinarians throughout North America to focus on what matters most – providing best-in-class care. Practices can get up and running quickly and manage their plans easily.
  • Scratchpay: This simple and unique financing platform is designed to increase access to healthcare through immediate and transparent payment plans and touchless payments. The platform makes patient financing easy and transparent for practices. Clients can apply for financial support in just 90 seconds via any internet-connected device. Once a payment plan is selected by the client, practices receive the funds in as little as two to three business days while the client pays over time with no deferred interest or prepayment fees. Scratchpay positions itself as the most accessible “Care Now, Pay Later” provider for pets in the U.S. 

MWI’s latest offerings expand upon the company’s commitment to helping veterinarians manage the impact of COVID-19. In April, MWI announced a series of technology tools to facilitate virtual engagement between practices and clients.

For more information about MWI Animal Health and how to incorporate new financing and technology solutions into your veterinary practice, please visit www.mwiah.com.

###

About AmerisourceBergen
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work — and powered by our 22,000 associates — we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $175 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.

Press release

IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

October 16, 2025

Media statement

Cencora to Support Commercial Launch of Precigen’s Novel Immunotherapy in the United States

September 24, 2025

Media mention

ThoughtSpot 2025 Highlights Cencora’s Commitment to Advancing the Future of Pharmacy and Ensuring Medication Access

August 27, 2025

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.